Indication
Cytomegalovirus Viremia
4 clinical trials
4 products
Clinical trial
Treatment of CMV Infections With Viral-Specific T Cells Against CMV in Pediatric and Adult Immunocompromised Patients or Recipients of Allogeneic Stem Cell TransplantationStatus: Recruiting, Estimated PCD: 2025-09-01
Product
CMV-specific T-cellsClinical trial
Expansion of Virus-Specific Lymphocytes for Cell Therapy in Immunosuppressed Patients Who Underwent Bone Marrow Transplantation.Status: Recruiting, Estimated PCD: 2024-06-10
Product
Lymphocyte infusionClinical trial
A Prospective Multicenter Open-label, Not Controlled Phase Ib-II Clinical Trial to Assess the Safety and Immunologic Efficacy of Virus-specific T Lymphocytes From the Best Donor in Receptors of Hematopoietic Progenitor Allogeneic TransplantStatus: Completed, Estimated PCD: 2021-10-18
Product
Activated T-LymphocytesClinical trial
A Phase II Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell TransplantationStatus: Recruiting, Estimated PCD: 2024-06-01
Product
CMVpp65 Specific T-cells